Investorideas.com  big ideas for global investors Search www.investorideas.com
   Member Access       Sign-up       Newsfeeds        Companies        Stock Directories       Research       Video       Funding   




Stevia / LOHAS Stock Alert: GLG (TSX: GLG) (OTC: GLGLF) Announces FDA's Issuance of Letter of no Objection for Rebsweet(TM) and AnySweetPLUS(TM) Stevia Extracts

Ideas get bigger when you share them...

Vancouver, B.C. - June 4, 2014 (Investorideas.com Newswire) GLG Life Tech Corporation (TSX: GLG) (OTC: GLGLF) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality natural sweeteners, announces that the United States Food and Drug Administration ("FDA") has issued a Generally Recognized as Safe ("GRAS") letter of no objection covering several of GLG's high-purity stevia extracts (Filing No. GRN 493). These extracts, each containing over 95% steviol glycosides (predominantly rebaudioside A and stevioside), include GLG's Rebsweet(TM) and AnySweetPLUS(TM) stevia extract products (with rebaudioside A content ranging from 50% to 85%).

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

The GRAS program is an FDA-approved process that enables companies to conduct independent GRAS determinations through consultations with qualified experts to determine that an ingredient satisfies the FDA's safety criteria. Accordingly, GLG engaged GRAS Associates, LLC, who convened an independent panel of expert scientists to spearhead the safety assessment and compile a dossier describing the months-long study and its results. GLG subsequently submitted that dossier to the FDA for review, resulting in the FDA's letter of no objection.

The latest GRAS designations further GLG's commitment to maintaining the highest quality standards for its products. To date, it has received five GRAS letters of no objection covering an array of high-purity stevia products, with a sixth GRAS determination pending FDA review (for high-purity rebaudioside M) and two other GRAS projects currently underway (for high-purity rebaudioside C and D). Additionally, GLG recently announced its submission of a GRAS notification to the FDA for its Luo Han Guo (Monk Fruit) extract products. GLG has the largest number of stevia products certified under the GRAS process, and remains committed to ensuring that each of its naturally-sourced sweetener products conforms with the GRAS compliance standards.

About GLG Life Tech Corporation

GLG Life Tech Corporation is a global leader in the supply of high purity stevia extracts, an all-natural zero-calorie sweetener used in food and beverages. The Company's vertically integrated operations cover each step in the stevia supply chain including non-GMO stevia seed breeding, natural propagation, stevia leaf growth and harvest, proprietary extraction and refining, marketing and distribution of finished product. For further information, please visit www.glglifetech.com.

Forward-looking statements: This press release contains certain information that may constitute "forward-looking statements" and "forward looking information" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Such forward-looking statements include, without limitation, statements evaluating the market, potential demand for stevia and general economic conditions and discussing future-oriented costs and expenditures. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" or variations of such words and phrases or words and phrases that state or indicate that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.

While the Company has based these forward-looking statements on its current expectations about future events, the statements are not guarantees of the Company's future performance and are subject to risks, uncertainties, assumptions and other factors which could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Such factors include amongst others the effects of general economic conditions, consumer demand for our products and new orders from our customers and distributors, changing foreign exchange rates and actions by government authorities, uncertainties associated with legal proceedings and negotiations, industry supply levels, competitive pricing pressures and misjudgments in the course of preparing forward-looking statements. Specific reference is made to the risks set forth under the heading "Risk Factors" in the Company's Annual Information Form for the financial year ended December 31, 2012. In light of these factors, the forward-looking events discussed in this press release might not occur.

Further, although the Company has attempted to identify factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

As there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements, readers should not place undue reliance on forward-looking statements.

Contact:

Stuart Wooldridge, Investor Relations
Phone: +1 (604) 669-2602 ext. 104
Fax: +1 (604) 662-8858
Email: ir@glglifetech.com

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers Disclosure: GLG Life Tech Corporation (TSX: GLG) April 9th 2014 - two months news and content publication , two thousand five hundred per month. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Free News Alerts
Email:  

Read more News





TOP

Investor Ideas © 2000 - 2014 InvestorIdeas.com®, ECON

Free Investor Stock Alerts
Sign up here

login | logout | about us | contact | disclaimer / disclosure |
advertise | company profile directory | partners / links |
job search | privacy policy | trade | services | sitemap |